Y-mAbs Therapeutics Inc. (YMAB)
NASDAQ: YMAB
· Real-Time Price · USD
8.61
0.02 (0.23%)
At close: Sep 15, 2025, 3:59 PM
Y-mAbs Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for YMAB stock have an median target of 12, with a low estimate of 7 and a high estimate of 17. The median target predicts an increase of 39.37% from the current stock price of 8.61.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 7 | 11.74 | 12 | 17 |
| Change | -18.70% | 36.35% | 39.37% | 97.44% |
Latest Analyst Insight Report
HC Wainwright & Co. downgraded Y-mAbs Therapeutics... Unlock content with Pro Subscription
Updated Aug 06, 2025
| Rating | Nov 24 | Dec 24 | Jan 25 | Mar 25 | May 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 1 | 3 | 4 | 0 |
| Hold | 0 | 0 | 0 | 1 | 0 | 3 |
| Sell | 0 | 0 | 0 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 5 | 4 | 3 |
Financial Forecast this Year
Revenue This Year
82.55M
from 87.69M
Increased by -5.9%
Revenue Next Year
95.28M
from 82.55M
Increased by 15.4%
EPS This Year
-0.8
from -0.67
Increased by -19.4%
EPS Next Year
-0.88
from -0.8
Increased by -10%